Hormonal Contraceptive Continuation and Switching in South Africa: Implications for Evaluating the Association of Injectable Hormonal Contraceptive Use and HIV

被引:17
作者
Smit, Jennifer A. [1 ]
Beksinska, Mags E. [1 ,2 ]
机构
[1] Univ Witwatersrand, Dept Obstet & Gynaecol, MatCH Maternal Adolescent & Child Hlth, Fac Hlth Sci, ZA-4091 Durban, South Africa
[2] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England
关键词
hormonal contraception; depot medroxyprogesterone; norethisterone enanthate; combined oral contraceptives; HIV; DISCONTINUATION; WOMEN; RISK; ACQUISITION; INFECTION; COHORT;
D O I
10.1097/QAI.0b013e31827e818a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Investigating the association between hormonal contraception and HIV is challenging due to high discontinuation rates among users. This secondary analysis of 262 South African adolescent new users of hormonal contraception found continuation rates after 1 year for depot medroxyprogesterone acetate, norethisterone enanthate, or combined oral contraceptives of 40.4%, 64.4%, and 64.6%, respectively. Implications for studies evaluating the association between injectable hormonal contraceptive use and HIV are discussed.
引用
收藏
页码:363 / 365
页数:3
相关论文
共 20 条
  • [1] Contraceptive Switching after Method-related Discontinuation: Levels and Differentials
    Ali, Mohamed M.
    Cleland, John
    [J]. STUDIES IN FAMILY PLANNING, 2010, 41 (02) : 129 - 133
  • [2] [Anonymous], S AFR DEM HLTH SURV
  • [3] [Anonymous], 2012, HORM CONTR HIV TECHN
  • [4] Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women
    Baeten, Jared M.
    Benki, Sarah
    Chohan, Vrasha
    Lavreys, Ludo
    McClelland, R. Scott
    Mandaliya, Kishorchandra
    Ndinya-Achola, Jeckoniah O.
    Jaoko, Walter
    Overbaugh, Julie
    [J]. AIDS, 2007, 21 (13) : 1771 - 1777
  • [5] What Differentiates Method Stoppers from Switchers? Contraceptive Discontinuation and Switching Among Honduran Women
    Barden-O'Fallon, Janine
    Speizer, Ilene
    [J]. INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2011, 37 (01) : 16 - 23
  • [6] Beksinska ME, 2012, LANCET INFECT DIS, V12, P509, DOI 10.1016/S1473-3099(12)70109-3
  • [7] Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception
    Beksinska, Mags E.
    Kleinschmidt, Immo
    Smit, Jenni A.
    Farley, Timothy M. M.
    Rees, Helen V.
    [J]. CONTRACEPTION, 2009, 80 (02) : 128 - 132
  • [8] Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate
    Beksinska, Mags E.
    Kleinschmidt, Immo
    Smit, Jenni A.
    Farley, Timothy M. M.
    [J]. CONTRACEPTION, 2009, 79 (05) : 345 - 349
  • [9] Temporary discontinuation: a compliance issue in injectable users
    Beksinska, ME
    Rees, HV
    Smit, J
    [J]. CONTRACEPTION, 2001, 64 (05) : 309 - 313
  • [10] Beksinska ME, 1998, BRIT J FAM PLAN, V24, P21